The rising cost of pharmaceutical expenditure in many European countries is
of concern to governments required to make effective use of health care budgets.
Taking a broad perspective that encompasses the institutional, political and
supranational aspects of pharmaceutical regulation, this book examines the
approaches used to manage pharmaceutical expenditure across Europe and what
impact they have had on the efficiency, equity, quality and cost of
pharmaceutical care. Regulating pharmaceuticals in Europe is an important book
for students of health policy, regulation and management, and for health
managers and policy-makers.